Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plasma estrogen levels, estrogen receptor gene variation, and ischemic arterial disease in postmenopausal women: the three-city prospective cohort study.
Scarabin-Carré V, Brailly-Tabard S, Ancelin ML, Maubaret C, Guiochon-Mantel A, Canonico M, Scarabin PY. Scarabin-Carré V, et al. Among authors: canonico m. J Clin Endocrinol Metab. 2014 Aug;99(8):E1539-46. doi: 10.1210/jc.2013-4472. Epub 2014 May 13. J Clin Endocrinol Metab. 2014. PMID: 24823458 Free article.
Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
Canonico M, Oger E, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; EStrogen and THromboEmbolism Risk (ESTHER) Study Group. Canonico M, et al. J Thromb Haemost. 2006 Jun;4(6):1259-65. doi: 10.1111/j.1538-7836.2006.01933.x. J Thromb Haemost. 2006. PMID: 16706969 Free article.
Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Lévesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Canonico M, et al. Circulation. 2007 Feb 20;115(7):840-5. doi: 10.1161/CIRCULATIONAHA.106.642280. Circulation. 2007. PMID: 17309934 Clinical Trial.
Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
Bouaziz E, Canonico M, Verstuyft C, Carcaillon L, Martin F, Scarabin PY, Guiochon-Mantel A; EStrogen, THromboEmbolism Risk (ESTHER) Study Group. Bouaziz E, et al. Among authors: canonico m. Maturitas. 2009 Oct 20;64(2):136-8. doi: 10.1016/j.maturitas.2009.08.013. Epub 2009 Sep 25. Maturitas. 2009. PMID: 19782484 Free article.
135 results